https://orcid.org/0000-0003-2880-6850
Key Points
Sign and symptom scores represent distinct dimensions of post-thrombotic syndrome, relating differently to clinical profiles and outcomes.
Clinicians should recognize that combining these scores may obscure risk-stratification and impede personalized treatment strategies.
Post-thrombotic syndrome (PTS) is a heterogenous chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to investigate the heterogeneity of PTS among patients and within the Villalta scale. In 818 patients from the IDEAL-DVT study, clustering identified four distinct clinical profiles: (1) younger patients with provoked DVT, (2) women with joint pain, (3) men with isolated popliteal DVT, and (4) older men with diabetes and femoral vein involvement. Clustering of Villalta scale items revealed a clear distinction between signs and symptoms. Sign scores significantly increased with older age, male sex, higher body mass index (BMI), and DVT extent, whereas symptom scores increased with younger age, female sex, higher BMI, and provoked DVT. Residual venous obstruction was associated with the sign score (odds ratio 1.18 [1.06-1.31] per point) but not the symptom score. Quality of life was more closely related to the symptom score than the sign score (VEINES-QoL -3.5% [p<0.001] vs -1.6% [p<0.001] per point). At six months, sign and symptom scores differed significantly across profiles, especially between profile 1 and 4, as the former had most symptoms (41% vs 21% ≥3 [p<0.001]) while the latter had most signs (18% vs 34% ≥3 [p=0.004]). After two years, symptoms decreased in profile 1 but increased in profile 4. Other profiles showed intermediate scores over time. These findings suggest that reappraising the PTS scoring system to distinguish its two dimensions would enable more personalized risk prediction and prevention. NCT 01429714
